Session » 4M092: Pediatric Rheumatology – Clinical II: JIA (1812–1817)
-
Abstract Number: 1812
Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis
-
Abstract Number: 1813
New Medications Are Needed for Children with Juvenile Idiopathic Arthritis
-
Abstract Number: 1814
Long-term Outcome of Juvenile Idiopathic Arthritis: From the Methotrexate to the Biologic Era
-
Abstract Number: 1815
Subcutaneous or Intravenous Abatacept Monotherapy in Pediatric Patients with Polyarticular-Course JIA: Results from Two Phase III Trials